Description
Genomic Health 09-060: A real-world observational study to provide prospective information on the management of patients with metastatic castration-resistant prostate cancer (mCRPC) with disease progression after at least one line of androgen receptor-targeted therapy (ARTT) and the use of the Oncotype DX AR-V7 Nucleus Detect® assay in subsequent management
Location: SIMR (Sacramento/Valley Area)
Please contact: Kirsten Babski babskik@sutterhealth.org about study Genomic Health Oncotype DX AR-V7
Principal Investigator
Co-Investigator(s)
Brian K. Kim, M.D, Kristin N. Arreola, M.D., Rajeswari Chellappah, M.D., Nitin Rohatgi, MD, Vijay Suhag, M.D., Kristie A. Bobolis, M.D., Sivakumar Reddy, M.D.
Recruitment Status
Active, Not Recruiting
Start Date
May 20, 2020
Research Topics
Related Studies
Locally Advanced (ECOG-ACRIN EA8183)
Investigator: Edmund W. Tai, M.D.